These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26021727)

  • 21. Methodological Challenges in Studying Autism Spectrum Disorder.
    Monuteaux MC
    J Am Acad Child Adolesc Psychiatry; 2018 Nov; 57(11):824-825. PubMed ID: 30392622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmunity, Autoantibodies, and Autism Spectrum Disorder.
    Edmiston E; Ashwood P; Van de Water J
    Biol Psychiatry; 2017 Mar; 81(5):383-390. PubMed ID: 28340985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune dysregulation and autoimmunity in bipolar disorder: Synthesis of the evidence and its clinical application.
    Rege S; Hodgkinson SJ
    Aust N Z J Psychiatry; 2013 Dec; 47(12):1136-51. PubMed ID: 23908311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics.
    Uzunova G; Pallanti S; Hollander E
    World J Biol Psychiatry; 2016 Apr; 17(3):174-86. PubMed ID: 26469219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT).
    Ni W; Watts SW
    Clin Exp Pharmacol Physiol; 2006 Jul; 33(7):575-83. PubMed ID: 16789923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of developmental hyperserotonemia on the morphology of rat dentate nuclear neurons.
    Hough LH; Segal S
    Neuroscience; 2016 May; 322():178-94. PubMed ID: 26892293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism.
    Coutinho AM; Oliveira G; Morgadinho T; Fesel C; Macedo TR; Bento C; Marques C; Ataíde A; Miguel T; Borges L; Vicente AM
    Mol Psychiatry; 2004 Mar; 9(3):264-71. PubMed ID: 15094787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microglia in the pathogenesis of autism spectrum disorders.
    Koyama R; Ikegaya Y
    Neurosci Res; 2015 Nov; 100():1-5. PubMed ID: 26116891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of papaverine on developmental hyperserotonemia induced autism spectrum disorder related behavioural phenotypes by altering markers of neuronal function, inflammation, and oxidative stress in rats.
    Luhach K; Kulkarni GT; Singh VP; Sharma B
    Clin Exp Pharmacol Physiol; 2021 Apr; 48(4):614-625. PubMed ID: 33480092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions of innate and adaptive immunity in brain development and function.
    Filiano AJ; Gadani SP; Kipnis J
    Brain Res; 2015 Aug; 1617():18-27. PubMed ID: 25110235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autism spectrum disorders and natural killer cells: a review on pathogenesis and treatment.
    Ebrahimi Meimand S; Rostam-Abadi Y; Rezaei N
    Expert Rev Clin Immunol; 2021 Jan; 17(1):27-35. PubMed ID: 33191807
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk factors in autism: Thinking outside the brain.
    Matelski L; Van de Water J
    J Autoimmun; 2016 Feb; 67():1-7. PubMed ID: 26725748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin transporter deficiency in rats contributes to impaired object memory.
    Olivier JD; Jans LA; Blokland A; Broers NJ; Homberg JR; Ellenbroek BA; Cools AR
    Genes Brain Behav; 2009 Nov; 8(8):829-34. PubMed ID: 19740092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and pharmacological manipulations of the serotonergic system in early life: neurodevelopmental underpinnings of autism-related behavior.
    Kinast K; Peeters D; Kolk SM; Schubert D; Homberg JR
    Front Cell Neurosci; 2013; 7():72. PubMed ID: 23781172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders.
    Theoharides TC; Tsilioni I; Patel AB; Doyle R
    Transl Psychiatry; 2016 Jun; 6(6):e844. PubMed ID: 27351598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells.
    Launay JM; Schneider B; Loric S; Da Prada M; Kellermann O
    FASEB J; 2006 Sep; 20(11):1843-54. PubMed ID: 16940156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the serotonin transporter and prenatal cortisol in the development of autism spectrum disorders.
    Rose'meyer R
    Mol Autism; 2013 Oct; 4(1):37. PubMed ID: 24103554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?
    Robinson-Agramonte MLA; Noris García E; Fraga Guerra J; Vega Hurtado Y; Antonucci N; Semprún-Hernández N; Schultz S; Siniscalco D
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neural activity, memory, and dementias: serotonergic markers.
    Meneses A
    Behav Pharmacol; 2017 Apr; 28(2 and 3-Spec Issue):132-141. PubMed ID: 27926574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical clues for autoimmunity and neuroinflammation in patients with autistic regression.
    Scott O; Shi D; Andriashek D; Clark B; Goez HR
    Dev Med Child Neurol; 2017 Sep; 59(9):947-951. PubMed ID: 28383115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.